Ewing's sarcoma of the pelvis

R. Capanna, A. Toni, A. Sudanese, D. McDonald, G. Bacci, M. Campanacci

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Two hundred and thirty-nine patients with Ewing's sarcoma were treated at our institution between 1972 and 1987: 42 of these had lesions in the pelvis, 29 were in the wing of the ilium or involved the sacroiliac joint (type I), 5 were periacetabular (type II), and 8 were in the anterior pelvic arch (type III). Radiotherapy alone was used for the primary lesion in 11 cases, adjuvant chemotherapy in 20 and a neoadjuvant protocol in 22. The overall disease-free survival at a mean follow up of 34 months was 19%. There was no difference in survival related to age or the site in the pelvis, none in disease-free survival with adjuvant and neoadjuvant chemotherapy, or in the incidence of local recurrence and metastases in these two groups. Similarly, there was no difference in disease-free survival between operative treatment, with or without radiotherapy, and radiotherapy alone. There was a slight trend towards better local control of the disease in the former group compared to the latter, although this difference was not statistically significant. Our conclusion is that treatment needs to be planned for each individual patient.

Original languageEnglish
Pages (from-to)57-61
Number of pages5
JournalInternational Orthopaedics
Volume14
Issue number1
DOIs
Publication statusPublished - Mar 1990

Fingerprint

Ewing's Sarcoma
Pelvis
Disease-Free Survival
Radiotherapy
Adjuvant Chemotherapy
Ilium
Sacroiliac Joint
Neoplasm Metastasis
Recurrence
Survival
Incidence
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Capanna, R., Toni, A., Sudanese, A., McDonald, D., Bacci, G., & Campanacci, M. (1990). Ewing's sarcoma of the pelvis. International Orthopaedics, 14(1), 57-61. https://doi.org/10.1007/BF00183366

Ewing's sarcoma of the pelvis. / Capanna, R.; Toni, A.; Sudanese, A.; McDonald, D.; Bacci, G.; Campanacci, M.

In: International Orthopaedics, Vol. 14, No. 1, 03.1990, p. 57-61.

Research output: Contribution to journalArticle

Capanna, R, Toni, A, Sudanese, A, McDonald, D, Bacci, G & Campanacci, M 1990, 'Ewing's sarcoma of the pelvis', International Orthopaedics, vol. 14, no. 1, pp. 57-61. https://doi.org/10.1007/BF00183366
Capanna R, Toni A, Sudanese A, McDonald D, Bacci G, Campanacci M. Ewing's sarcoma of the pelvis. International Orthopaedics. 1990 Mar;14(1):57-61. https://doi.org/10.1007/BF00183366
Capanna, R. ; Toni, A. ; Sudanese, A. ; McDonald, D. ; Bacci, G. ; Campanacci, M. / Ewing's sarcoma of the pelvis. In: International Orthopaedics. 1990 ; Vol. 14, No. 1. pp. 57-61.
@article{c53bb1fdccfc4726b791d85b740cbdb0,
title = "Ewing's sarcoma of the pelvis",
abstract = "Two hundred and thirty-nine patients with Ewing's sarcoma were treated at our institution between 1972 and 1987: 42 of these had lesions in the pelvis, 29 were in the wing of the ilium or involved the sacroiliac joint (type I), 5 were periacetabular (type II), and 8 were in the anterior pelvic arch (type III). Radiotherapy alone was used for the primary lesion in 11 cases, adjuvant chemotherapy in 20 and a neoadjuvant protocol in 22. The overall disease-free survival at a mean follow up of 34 months was 19{\%}. There was no difference in survival related to age or the site in the pelvis, none in disease-free survival with adjuvant and neoadjuvant chemotherapy, or in the incidence of local recurrence and metastases in these two groups. Similarly, there was no difference in disease-free survival between operative treatment, with or without radiotherapy, and radiotherapy alone. There was a slight trend towards better local control of the disease in the former group compared to the latter, although this difference was not statistically significant. Our conclusion is that treatment needs to be planned for each individual patient.",
author = "R. Capanna and A. Toni and A. Sudanese and D. McDonald and G. Bacci and M. Campanacci",
year = "1990",
month = "3",
doi = "10.1007/BF00183366",
language = "English",
volume = "14",
pages = "57--61",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Ewing's sarcoma of the pelvis

AU - Capanna, R.

AU - Toni, A.

AU - Sudanese, A.

AU - McDonald, D.

AU - Bacci, G.

AU - Campanacci, M.

PY - 1990/3

Y1 - 1990/3

N2 - Two hundred and thirty-nine patients with Ewing's sarcoma were treated at our institution between 1972 and 1987: 42 of these had lesions in the pelvis, 29 were in the wing of the ilium or involved the sacroiliac joint (type I), 5 were periacetabular (type II), and 8 were in the anterior pelvic arch (type III). Radiotherapy alone was used for the primary lesion in 11 cases, adjuvant chemotherapy in 20 and a neoadjuvant protocol in 22. The overall disease-free survival at a mean follow up of 34 months was 19%. There was no difference in survival related to age or the site in the pelvis, none in disease-free survival with adjuvant and neoadjuvant chemotherapy, or in the incidence of local recurrence and metastases in these two groups. Similarly, there was no difference in disease-free survival between operative treatment, with or without radiotherapy, and radiotherapy alone. There was a slight trend towards better local control of the disease in the former group compared to the latter, although this difference was not statistically significant. Our conclusion is that treatment needs to be planned for each individual patient.

AB - Two hundred and thirty-nine patients with Ewing's sarcoma were treated at our institution between 1972 and 1987: 42 of these had lesions in the pelvis, 29 were in the wing of the ilium or involved the sacroiliac joint (type I), 5 were periacetabular (type II), and 8 were in the anterior pelvic arch (type III). Radiotherapy alone was used for the primary lesion in 11 cases, adjuvant chemotherapy in 20 and a neoadjuvant protocol in 22. The overall disease-free survival at a mean follow up of 34 months was 19%. There was no difference in survival related to age or the site in the pelvis, none in disease-free survival with adjuvant and neoadjuvant chemotherapy, or in the incidence of local recurrence and metastases in these two groups. Similarly, there was no difference in disease-free survival between operative treatment, with or without radiotherapy, and radiotherapy alone. There was a slight trend towards better local control of the disease in the former group compared to the latter, although this difference was not statistically significant. Our conclusion is that treatment needs to be planned for each individual patient.

UR - http://www.scopus.com/inward/record.url?scp=0025214442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025214442&partnerID=8YFLogxK

U2 - 10.1007/BF00183366

DO - 10.1007/BF00183366

M3 - Article

VL - 14

SP - 57

EP - 61

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

IS - 1

ER -